CB Insights
Technology Market Intelligence
Technology Market Intelligence
Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The Company's epigenetic drug discovery platfor...Show all
Company (Acquired)
Phone: 617-245-1300
70 Fargo Street
Suite 205
Boston, 02210
Massachusetts, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Acetylon Pharmaceuticals | $156.1M | Dec 2, 2016 |
| Xanthus Pharmaceuticals | $63.8M | Jun 9, 2008 |
| HNC Software | $0M | May 2, 2002 |
| See all 37 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Phenyl and pyridinyl hydroxamic acids | Jul 19, 2019 | Feb 23, 2021 | Patent |
| Combinations of histone deacetylase inhibitors and either her2 inhibitors or pi3k inhibitors | Jun 22, 2016 | Jul 28, 2020 | Patent |
| Biomarkers to identify patients that will respond to treatment and treating such patients | Apr 26, 2017 | May 12, 2020 | Patent |
| Crystalline forms of a histone deacetylase inhibitor | Jun 08, 2016 | Nov 05, 2019 | Patent |
| Phenyl and pyridinyl hydroxamic acids | Nov 09, 2017 | Aug 06, 2019 | Patent |
